These trials are currently recruiting subjects and are available through the BMC Parkinson's Disease and Movement Disorders Center.
For information, please contact Ray James, RN at 617.638.7745.
- Parkinson's Progression Markers Initiative (PPMI)
- Study in Parkinson Disease of Exercise Phase 3 Clinical Trial (SPARX3)
- A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson’s Disease (LUMA)
- Trial of Parkinson’s and Zoledronic Acid (TOPAZ)
- Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease (FIRE-UP PD)
- Biomarker Study (SEARCH PD)